Collectively, our cell culture results and correlations observed in the clinical samples imply that in vivo estrogen-induced phosphorylation of FAK is mediated through GPR30 rather than nuclear ERα in human endometrial cancers with low ERα. This evidence concerns the gene PTK2 and endometrial cancer.